These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9722511)

  • 1. Cooperative interaction between alpha- and beta-chains of hepatocyte growth factor on c-Met receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responses.
    Matsumoto K; Kataoka H; Date K; Nakamura T
    J Biol Chem; 1998 Sep; 273(36):22913-20. PubMed ID: 9722511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor.
    Date K; Matsumoto K; Shimura H; Tanaka M; Nakamura T
    FEBS Lett; 1997 Dec; 420(1):1-6. PubMed ID: 9450538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells.
    Parr C; Hiscox S; Nakamura T; Matsumoto K; Jiang WG
    Int J Cancer; 2000 Feb; 85(4):563-70. PubMed ID: 10699931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells.
    Kuba K; Matsumoto K; Ohnishi K; Shiratsuchi T; Tanaka M; Nakamura T
    Biochem Biophys Res Commun; 2000 Dec; 279(3):846-52. PubMed ID: 11162438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor.
    Date K; Matsumoto K; Kuba K; Shimura H; Tanaka M; Nakamura T
    Oncogene; 1998 Dec; 17(23):3045-54. PubMed ID: 9881707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HGF-MET cascade, a key target for inhibiting cancer metastasis: the impact of NK4 discovery on cancer biology and therapeutics.
    Mizuno S; Nakamura T
    Int J Mol Sci; 2013 Jan; 14(1):888-919. PubMed ID: 23296269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling.
    Kirchhofer D; Yao X; Peek M; Eigenbrot C; Lipari MT; Billeci KL; Maun HR; Moran P; Santell L; Wiesmann C; Lazarus RA
    J Biol Chem; 2004 Sep; 279(38):39915-24. PubMed ID: 15218027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK4 gene therapy targeting HGF-Met and angiogenesis.
    Matsumoto K; Nakamura T
    Front Biosci; 2008 Jan; 13():1943-51. PubMed ID: 17981681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4.
    Hiscox S; Parr C; Nakamura T; Matsumoto K; Mansel RE; Jiang WG
    Breast Cancer Res Treat; 2000 Feb; 59(3):245-54. PubMed ID: 10832594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide.
    Tam EM; Runyon ST; Santell L; Quan C; Yao X; Kirchhofer D; Skelton NJ; Lazarus RA
    J Mol Biol; 2009 Jan; 385(1):79-90. PubMed ID: 18973760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo.
    Davies G; Mason MD; Martin TA; Parr C; Watkins G; Lane J; Matsumoto K; Nakamura T; Jiang WG
    Int J Cancer; 2003 Sep; 106(3):348-54. PubMed ID: 12845672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of functional domains in the hepatocyte growth factor and its receptor by molecular engineering.
    Bardelli A; Ponzetto C; Comoglio PM
    J Biotechnol; 1994 Sep; 37(2):109-22. PubMed ID: 7765452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells.
    Qian LW; Mizumoto K; Inadome N; Nagai E; Sato N; Matsumoto K; Nakamura T; Tanaka M
    Int J Cancer; 2003 May; 104(5):542-9. PubMed ID: 12594808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell and neutrophil peptidases attack an inactivation segment in hepatocyte growth factor to generate NK4-like antagonists.
    Raymond WW; Cruz AC; Caughey GH
    J Biol Chem; 2006 Jan; 281(3):1489-94. PubMed ID: 16303761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis.
    Hartmann G; Naldini L; Weidner KM; Sachs M; Vigna E; Comoglio PM; Birchmeier W
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11574-8. PubMed ID: 1280830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
    Suzuki Y; Sakai K; Ueki J; Xu Q; Nakamura T; Shimada H; Nakamura T; Matsumoto K
    Int J Cancer; 2010 Oct; 127(8):1948-57. PubMed ID: 20104519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling.
    Rubin JS; Day RM; Breckenridge D; Atabey N; Taylor WG; Stahl SJ; Wingfield PT; Kaufman JD; Schwall R; Bottaro DP
    J Biol Chem; 2001 Aug; 276(35):32977-83. PubMed ID: 11435444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric peptide activators of pro-hepatocyte growth factor stimulate Met signaling.
    Landgraf KE; Santell L; Billeci KL; Quan C; Young JC; Maun HR; Kirchhofer D; Lazarus RA
    J Biol Chem; 2010 Dec; 285(51):40362-72. PubMed ID: 20937841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.